Cargando…
MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification
BACKGROUND: Breast cancer is the most common cancer in women around the world, and the molecular mechanisms of breast cancer progression and metastasis are still unclear. This study aims to clarify the function and N6,2′-O-dimethyladenosine (m6A) regulation of lncRNA MIR210HG in breast cancer. RESUL...
Autores principales: | Shi, Wenjing, Tang, Yongzhe, Lu, Jing, Zhuang, Yihui, Wang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962467/ https://www.ncbi.nlm.nih.gov/pubmed/35346372 http://dx.doi.org/10.1186/s13578-022-00772-z |
Ejemplares similares
-
IGF2BP2-meidated m(6)A modification of CSF2 reprograms MSC to promote gastric cancer progression
por: Ji, Runbi, et al.
Publicado: (2023) -
m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2
por: Qian, Benheng, et al.
Publicado: (2021) -
METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3
por: Yi, Jianmei, et al.
Publicado: (2023) -
Hypoxia-Induced LncRNA-MIR210HG Promotes Cancer Progression By Inhibiting HIF-1α Degradation in Ovarian Cancer
por: Liu, Ping, et al.
Publicado: (2021) -
m(6)A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
por: Lang, Chuandong, et al.
Publicado: (2021)